What is the T(pot) for prostate cancer? Radiobiological implications of the equivalent outcome with (125)I or (103)Pd.
King
C R
CR
D000465:Algorithms; D002470:Cell Survival; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D016014:Linear Models; D008297:Male; D010165:Palladium / Q000627:therapeutic use*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000532:radiotherapy*; D011853:Radiobiology; D011868:Radioisotopes / Q000627:therapeutic use*; D012062:Relative Biological Effectiveness; D013997:Time Factors; D014407:Tumor Cells, Cultured
D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium; D017430:Prostate-Specific Antigen